Company Stock Information

Company Stock Data | Company Summary in Chinese | Company Press Release (65) | NAI Interview(0) | Company Event(0) | Research Report (0) | Chinese Micro Site | Contact Company
AVANIR PHARMACEUTICALS (NASDAQ:AVNR)
Show Interactive Chart | Add to Portfolio

Stock Info

Last Trade 0.000
Change 0.000
Change (%) %
Volume 0
10 Days Avg Vol 4,867,600
3 Months Avg Vol 6,618,700
52 Weeks Lo/Hi $ 3.02 - $ 17.05
YTD Price Gain % 0.1%
10 Wks Moving Avg $ 16
200 Days Moving Avg $ 9
Liquidity Ratio 230,454,000
Market Cap 3,286,147,603

Related News

TitleDate
Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder07/21/2014
Avanir Pharmaceuticals Announces Completion of Patient Enrollment in Study of AVP-923 for the Treatment of Agitation in Patients with Alzheimer's Disease05/26/2014
Avanir Pharmaceuticals Announces Acceptance of New Drug Application for AVP-825 for the Acute Treatment of Migraine03/25/2014
Avanir Pharmaceuticals Pre-Announces Preliminary Fiscal 2013 Year End Financial Information10/28/2013

Summary

Contact Info

AVANIR Pharmaceuticals Class A's address AVANIR Pharmaceuticals Class A
Suite 400 - 30 Enterprise
Aliso Viejo CA 92656
AVANIR Pharmaceuticals Class A's Telephne number (949) 389-6700
AVANIR Pharmaceuticals Class A's fax number (949) 389-6701
AVANIR Pharmaceuticals Class A's email account ir@avanir.com
AVANIR Pharmaceuticals Class A's web site www.avanir.com
Keith A. Katkin